Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Lung
Published in: Lung 3/2018

01-06-2018 | Author Correction

Correction to: Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH

Authors: Henning Gall, Jean-Luc Vachiéry, Nobuhiro Tanabe, Michael Halank, Mauricio Orozco-Levi, Lisa Mielniczuk, MiKyung Chang, Kai Vogtländer, Ekkehard Grünig

Published in: Lung | Issue 3/2018

Login to get access

Excerpt

The original version of this article unfortunately contained a mistake. In the “Results” section, the percentage of patients with inoperable or persistent/recurrent CTEPH included in the study was reported as 85%. This has been corrected to 68% with this erratum. …
Metadata
Title
Correction to: Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
Authors
Henning Gall
Jean-Luc Vachiéry
Nobuhiro Tanabe
Michael Halank
Mauricio Orozco-Levi
Lisa Mielniczuk
MiKyung Chang
Kai Vogtländer
Ekkehard Grünig
Publication date
01-06-2018
Publisher
Springer US
Published in
Lung / Issue 3/2018
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-018-0112-z

Other articles of this Issue 3/2018

Lung 3/2018 Go to the issue

PULMONARY HYPERTENSION

Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension

INTERSTITIAL LUNG DISEASE

Transient Blockade of Endothelin-1 Mitigates Amiodarone-Induced Pulmonary Fibrosis

PULMONARY HYPERTENSION

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH

Respiratory Mechanics

Alveolar Tidal recruitment/derecruitment and Overdistension During Four Levels of End-Expiratory Pressure with Protective Tidal Volume During Anesthesia in a Murine Lung-Healthy Model

ASTHMA

The Variants in the 3′ Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma

BRIEF REPORT

Transdiaphragmatic Migration of a Spinal Fixation Rod into the Lung
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits